Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis
Open Access
- 12 July 2017
- journal article
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 3 (3)
Abstract
Cross-sectional studies reveal an association between tuberculosis (TB) and chronic airflow obstruction, but cannot adequately address confounding. We hypothesised that treated pulmonary TB is an independent risk factor for chronic airflow obstruction.The Pulmones Post TB cohort study enrolled participants from Lima, Peru, aged 10–70 years with a history of drug-susceptible (DS)- or multidrug-resistant (MDR)-TB who had completed treatment and were clinically cured. Unexposed participants without TB were randomly selected from the same districts. We assessed respiratory symptoms, relevant environmental exposures, and spirometric lung function pre- and post-bronchodilator.In total, 144 participants with DS-TB, 33 with MDR-TB and 161 unexposed participants were fully evaluated. Compared with unexposed participants, MDR-TB patients had lower lung volumes (adjusted mean difference in forced vital capacity −370 mL, 95% CI −644– −97) and post-bronchodilator airflow obstruction (adjusted OR 4.89, 95% CI 1.27–18.78). Participants who had recovered from DS-TB did not have lower lung volumes than unexposed participants, but were more likely to have a reduced forced expiratory volume in 1 s/forced vital capacity ratio <0.70 (adjusted OR 2.47, 95% CI 1.01–6.03).Individuals successfully treated for TB may experience long-lasting sequelae. Interventions facilitating earlier TB treatment and management of chronic respiratory disease should be explored.Keywords
Funding Information
- Woolcock Institute of Medical Research
- Sydney Medical School
- National Health and Medical Research Council Tuberculosis Centre of Research Excellence
This publication has 39 references indexed in Scilit:
- The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot studyBMC Pulmonary Medicine, 2012
- Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary DiseasePLOS ONE, 2012
- WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateEuropean Respiratory Journal, 2011
- Scale-up of Multidrug-Resistant Tuberculosis Laboratory Services, PeruEmerging Infectious Diseases, 2008
- Long term efficacy of DOTS regimens for tuberculosis: systematic reviewBMJ, 2008
- Global burden of COPD: risk factors, prevalence, and future trendsThe Lancet, 2007
- International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyThe Lancet, 2007
- General considerations for lung function testingEuropean Respiratory Journal, 2005
- Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcomeArchives of Disease in Childhood, 2003
- Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatmentThorax, 2000